Among his current studies in Providence Care is an examination of the effects of esketamine and racemic ketamine for management of treatment-resistant depression. Dr. Gustavo Vazquez is also spearheading with his colleagues the development of the first online cognitive behavioral therapy (CBT) program for individuals with bipolar depression type 2 and residual depressive symptoms. This online program funded by Providence Care aims to address several barriers presented by in-person therapy, providing effective, accessible, and cost effective mental health care.
His main scholarly activity is currently focused on the study of the clinical features, neurocognitive characteristics and pharmacological treatments of unipolar depression and bipolar disorders.
Dr. Gustavo Vazquez is a Professor of Psychiatry, Psychology, Queen’s University. He was born in Buenos Aires (Argentina) and obtained his MD from the University of Buenos Aires (UBA) in 1990. After his residency training on psychiatry at the Alvarez General Hospital (Buenos Aires, Argentina) and the University Clinic Hospital San Carlos (Madrid, Spain) in 1996, he was first appointed as assistant professor of clinical psychiatry (UBA) until 1998 and then as associate professor at the University of Palermo (UP) (Buenos Aires, Argentina).
In 2002, he became professor of neuroscience at the UP, where he founded and directed the Department of Neuroscience and the Research Center on Neuroscience and Clinical Neuropsychology (2011). He is doctorate by research on assessing bipolar disorders (PhD in Psychiatry and Neuroscience) in 2008 (Argentine Catholic University, Buenos Aires, Argentina).
Dr. Vazquez was recently appointed as professor of psychiatry at Queen’s University (Kingston, Ontario, Canada) to join the department of psychiatry in August 2016 and is currently working at the Mood Disorders Research and Treatment Service in Providence Care hospital.
He is an active research member of the International Consortium for Psychotic and Bipolar Disorders Research, McLean Hospital, Harvard Medical School (Boston, US) since 2006. He has also worked as invitee professor at the International Mood Center University of California at San Diego, US (2006), the Hospital Clinic, Universidad de Barcelona, Barcelona, Spain (2011) and the Hospital Sant´ Andrea, Rome, Italy (2013)
He is an active member of different scientific societies, serving as president of the Argentine Association of Biological Psychiatry (AAPB) between 2002-2005, founding member of the International Society of Psychiatry of McLean Hospital (Harvard Medical School, Boston, US) in 2003, representative of Latin America for the International Society for Affective Disorders (ISAD) since 2005, founding member and president of the Argentine Chapter of the International Society for Bipolar Disorders (ISBD) (2007-2014), and counselor of the International Society for Bipolar Disorders (ISBD) (2010-2014).
Among other academic distinctions, he has received the World Psychiatric Association International Fellow Award (1996), the National Award on Biological Psychiatry of the Argentine Psychiatric Association (2002), the International Award of the Society of Biological Psychiatry (US) (2003), the Argentine Psychiatric Association National Award on Clinical Psychiatry (2012), the International Society for Bipolar Disorders (ISBD) Scholar Award (2015), the Dean´s Doctoral Award of Queen´s University Medical School (2018), and two PCH Research Innovation Grants (2019).
He has published one hundred and twelve articles in different leading international peer reviewed journals, two books (on Neuroscience and on Affective Disorders), sixteen book chapters and has presented his work and research in several international meetings and congresses all around the world.